-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
NORTHLAND Signs Agreement with Jiangsu Yaohai for Commissioned Services in the Preparation of Clinical Samples for NL003
On March 5, 2021, Mr. Xu Songshan, President of the company, and Mr. Wang Manchao, General Manager of Jiangsu Yaohai Biopharmaceutical Co., Ltd. (hereinafter referred to as "Yaohai Bio"), signed a commissioned service agreement for the preparation of samples used in the Phase III clinical study of NORTHLAND's NL003 project.
Building on the strong cooperation between the two parties, the second batch of clinical sample preparation will be deployed as scheduled. Under production-scale conditions, we will strictly adhere to GMP standards to produce high-quality clinical samples, thereby ensuring the supply of investigational drug for the Phase III clinical trial of the NL003 project and providing a solid guarantee for the smooth and timely conduct of the clinical trial.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005